Podcast 17 May 2024Isarna Therapeutics revolutionizes ophthalmology with antisense oligonucleotides German-headquartered Isarna Therapeutics is developing a portfolio of antisense therapies targeting an emerging therapeutic field in human biology – transforming growth factor beta (TGF-B) signaling. Precise modulation of TGF-B pathways using antisense therapy may result in safer and more effective treatment options for a broad range of indications. Isarna Therapeutics’s lead compound, ISTH0036, is in […] May 17, 2024 Share WhatsApp Twitter Linkedin Email
Expert Advice 16 May 2024 Types of clinical trial designs: The essentials The average journey of a drug from trial to market is 10.5 years. Delve into the different clinical trials designs and their specificities. May 16, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 May 2024 Five orthobiologics companies leading the way in the field Discover five of the top orthobiologics companies leading the way in the field, as the market is set to grow in the next few years. May 16, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 15 May 2024 Drugs for IgA nephropathy on the rise in the clinic As we observed IgA Nephropathy Awareness Day on May 14th, let us take a look at ongoing clinical trials for drugs that aim to make patient lives better. May 15, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by Lumicks 14 May 2024 Cell avidity-tuning ensures safe CAR-T therapy for solid tumors Learn more about the potential of cell avidity in designing potent and safe CAR-T treatments for solid tumors. May 14, 2024 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 13 May 2024 New antidepressants: tackling treatment resistant depression Take a look at how new antidepressants can more effectively tackle treatment resistant depression compared to more traditional treatments. May 13, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Expert Advice 10 May 2024 How to prepare for an interview at a biotech company Find out how to best prepare yourself for biotech interview questions after applying for a job at a company. May 10, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 10 May 2024Cytokinetics’ cardiovascular pipeline beats strong Discover Cytokinetics’ groundbreaking cardiovascular treatments, including heart drug aficamten, in our latest podcast with CEO Robert Blum. May 10, 2024 Share WhatsApp Twitter Linkedin Email
In Depth 9 May 2024 BTK inhibitors: can these drugs tackle cancer and autoimmunity? BTK inhibitors were first approved over a decade ago to treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune diseases. May 9, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 9 May 2024 The biggest private biotech investments in April 2024 The companies Xaira Therapeutics, Metsera, and Obsidian Therapeutics bagged the biggest private biotech investments in April 2024. May 9, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 8 May 2024 New treatment for pulmonary hypertension: what biotech holds in store? While it has been about managing pulmonary hypertension’s symptoms for a long time, new treatments are adressing the root of the disease. May 8, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 May 2024 Biotech in New Jersey: Nine companies leading the charge Delve into one of the most dynamic biotech region in the U.S. and discover nine New-Jersey-based companies to put on your radar. May 7, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email